What is Peramivir for treatment of influenza in patients who are admitted into the hospital?
Peramivir is an investigational intravenous (IV) antiviral drug used to treat patients admitted to the hospital with severe influenza infection. Peramivir is an investigational drug, meaning it has not yet been approved for use by the Food and Drug Administration (FDA). There are other antiviral drugs used to treat H1N1 influenza that are taken orally (Tamiflu) or inhaled (Relenza). But, there are no FDA-approved IV drugs to treat patients seriously ill with H1N1 influenza. However, because of the public health emergency caused by the 2009 H1N1 pandemic, the FDA recently issued an Emergency Use Authorization (EUA) to allow the use of Peramivir to treat certain patients who have severe illness. Peramavir is to be used only for patients who are unable to take other antiviral medications orally. It’s not intended to be used for patients who do not require hospitalization. Healthcare providers must get special permission to use this drug on patients.
Related Questions
- Our hospital is often required to send patients to another hospital for treatment. If this occurs, for example, with an AMI patient, how is the patient represented in our data collection?
- What is Peramivir for treatment of influenza in patients who are admitted into the hospital?
- Why Choose Treatment for Lung Infections at University of Colorado Hospital?
